Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415856 | EGFR x CD28 multispecific antibodies | Andrew J. Murphy, George D. Yancopoulos, Chia-Yang Lin, Lauric Haber | 2025-09-16 |
| 12331127 | Therapeutic uses of anti-GITR antibodies | Robert Babb, Drew Dudgeon, Yu-Hsuan Huang, Rosalynn Molden, William Olson +2 more | 2025-06-17 |
| 11912767 | EGFR × CD28 multispecific antibodies | Andrew J. Murphy, George D. Yancopoulos, Chia-Yang Lin, Lauric Haber | 2024-02-27 |
| 11787867 | Anti-GITR antibodies and uses thereof | Robert Babb, Drew Dudgeon, Yu-Hsuan Huang, Rosalynn Molden, William Olson +2 more | 2023-10-17 |
| 11548947 | Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof | Andrew J. Murphy, Janelle Waite, Erica Ullman, Aynur Hermann, Eric Smith +2 more | 2023-01-10 |
| 11453721 | Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof | Andrew J. Murphy, Janelle Waite, Erica Ullman, Aynur Hermann, Eric Smith +3 more | 2022-09-27 |
| 11414494 | Anti-GITR antibodies and uses thereof | Frank Delfino, Bei Wang | 2022-08-16 |
| 11396544 | Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof | Andrew J. Murphy, Janelle Waite, Erica Ullman, Aynur Hermann, Eric Smith +3 more | 2022-07-26 |
| 10738126 | Anti-GITR antibodies and uses thereof | Frank Delfino, Bei Wang | 2020-08-11 |
| 9556277 | Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A | Brendan J. Classon | 2017-01-31 |
| 8889133 | Methods of treating diabetes with Dll4 antagonists | — | 2014-11-18 |
| 8765125 | Methods of treating autoimmune diseases with Dll4 antagonists | — | 2014-07-01 |
| 8642741 | Human antibodies to human TNF-like ligand 1A (TL1A) | Brendan J. Classon | 2014-02-04 |